AI model predicts which breast-cancer drugs work best

An AI model trained on millions of protein measurements can predict which drugs will be most effective in tissue samples from people with triple-negative breast cancer. It gauges drug effectiveness directly from proteomic profiling of biopsy material, in a subtype with historically limited targeted treatment options.